You are viewing the site in preview mode

Skip to content

Advertisement

  • Poster presentation
  • Open Access

Acute hemorrhagic encephalopathy - diagnostic challenges in a pediatric case

  • 1Email author,
  • 1, 2,
  • 1,
  • 1,
  • 1, 2,
  • 1, 2,
  • 1,
  • 1,
  • 1,
  • 1, 2,
  • 1,
  • 1,
  • 1 and
  • 1
BMC Infectious Diseases201313 (Suppl 1) :P101

https://doi.org/10.1186/1471-2334-13-S1-P101

  • Published:

Keywords

  • Vasculitis
  • Status Epilepticus
  • Encephalomyelitis
  • Neurologic Sign
  • Therapeutic Management

Background

Acute hemorrhagic encephalomyelitis (AHEM) is considered a rare form of Acute disseminated encephalomyelitis (ADEM), due to acute cerebral vasculitis. The symptomatology consists in similar neurological findings, (meningismus, headache, seizures, multifocal neurologic signs, asymmetrical neurological deficits and coma) with rapid onset of encephalopathy and biphasic evolution. Although previous respiratory disease was registered days before this condition, establishing etiology is quite a challenge, viruses being incriminated.

Case report

This report shows 10 months-old patient who presented with fever, seizures, multifocal neurological signs, with negative serological findings and initial favorable outcome, who developed severe neurological worsening after 3 weeks of treatment.

First magnetic resonance image (MRI) showed multifocal hyper-intense lesions affecting the CNS white matter. After 3 weeks from the initial symptoms, he had recurrence of his symptoms in association with rapidly progressive refractory status epilepticus and the second MRI showed micro-hemorrhagic lesions.

Aggressive therapeutic management was required in order to avoid the predictable fatal outcome.

Authors’ Affiliations

(1)
National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest, Romania
(2)
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Copyright

© Drăgănescu et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement